Executive Summary How Project Optimus Is Reshaping Oncology Development A panel of experts at BIO 2025 explored the transformative impact of Project Optimus, a Read Now Info Sheet Advancing Lung Cancer Trials with Precision Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related deaths Read Now Case Study Niche CRO’s Growing Outsourcing Needs Catalyst Flex helped support a niche contract research organization (CRO) with resources across multiple global studies ensuring the CRO was able to meet its clients’ needs via a cost-effective solution. Read Now Case Study Biometric Services for Large Pharmaceutical Company Catalyst Flex helped a global biopharmaceutical company with biometric resources to support its large portfolio of studies. Read Now Case Study Successful Global Site Engagement Solution Customized site engagement solution designed to meet the unique needs of a global pharmaceutical company. Read Now Case Study Assisting a Large Global Sponsor for Oncology Studies Catalyst Flex helped a global pharmaceutical company with resources for its large portfolio of studies. Catalyst Flex quickly stepped in to provide a team of talented individuals with the functional expertise required to deliver our client’s projects. Read Now Info Sheet Developing Cutting-edge Treatments for Ovarian Cancer The second most common gynecological cancer in the world is ovarian cancer. Often diagnosed at Read Now Case Study Oversight Monitoring Successes  A biopharmaceutical company engaged Catalyst Flex to provide appropriate and impartial oversight monitoring for several studies. Such services can help to prevent a sponsor from receiving findings during U.S. Food and Drug Administration (FDA) audits and in particular any Form FDA 483.  Read Now Info Sheet Early-Phase Oncology Research Expertise Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now Case Study Comprehensive and Flexible Partnership to Support Rescue Study  A biotech company new to clinical research with an asset early in its development lifecycle became a long-term partner with Catalyst Flex. For years, Catalyst has worked alongside to help achieve the client’s goals for a single asset for the first bladder cancer therapy on the horizon in the past 20 years. Read Now